A CAIX Dual-Targeting Small-Molecule Probe for Noninvasive Imaging of ccRCC-Reference-Cited by-同舟云学术

A CAIX Dual-Targeting Small-Molecule Probe for Noninvasive Imaging of ccRCC

Published:2024-06-04 Issue:7 Volume:21 Page:3383-3394
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

He Chengxue¹²,Liu Futao²,Tao Jinping¹²,Wang Zilei²,Liu Jiayue²,Liu Song²,Xu Xiaoxia²,Li Liqiang²,Wang Feng²,Yang Xianteng¹³,Zhu Hua¹²^ORCID,Yang Zhi¹²^ORCID

Affiliation:

1. Medical College, Guizhou University, Guiyang 550025, China

2. State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing 100142, China

3. Department of Orthopedics, Guizhou Provincial People’s Hospital,Anshun550002, China

Funder

National Key Research and Development Program of China

National Natural Science Foundation of China

Beijing Municipal Medical Research Institute

Science Foundation of Peking University Cancer Hospital

Beijing Hospital Authority Dengfeng project

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.4c00104

Reference35 articles.

1. Cancer statistics, 2023

2. Battaglia, M.; Lucarelli, G. The role of renal surgery in the era of targeted therapy: the urologist’s perspective. SAGE Publications Sage UK: London, England, 2015; Vol. 82, pp 137–138.

3. The evolving role of monoclonal antibodies in the treatment of patients with advanced renal cell carcinoma: a systematic review

4. Imaging for the diagnosis and response assessment of renal tumours